Further to my previous post about the complaint about Cochrane’s Editor in Chief, I wrote to the Cochrane support address given if you want to contact Cochrane’s Governing Board. 24 June 2023 Dear Cochrane Support (cc Gillian Leng, Lorraine Ross, Charity Commission) I have asked at least once for you to forward correspondence regarding complaints… Continue reading Email to Cochrane Governing Board: 24 June 2023
Tag: NICE
Complaint to Cochrane about Editor-in-Chief: March 2023
Below is the text of a formal complaint I made in March this year. Unlike previous complaints – I’ve been plugging away since 2018 – this one was specifically about the actions of the Editor-in-Chief. It focuses on her decision to allow the authors of the Exercise for CFS review to update the review, instead… Continue reading Complaint to Cochrane about Editor-in-Chief: March 2023
Letter to Cochrane with a suggestion about the update to the Exercise therapy for ME/CFS review: 19 March 2022
Yesterday I wrote to Rachel Marshall, the Cochrane Senior Editor who is managing the project to update Cochrane’s review of Exercise Therapy for ME/CFS. There have been no updates on the progress of the review since July last year, despite a commitment from Cochrane to keep patient groups regularly informed of progress.” I copied in… Continue reading Letter to Cochrane with a suggestion about the update to the Exercise therapy for ME/CFS review: 19 March 2022
Reply from Gill Leng, ex-CEO of NICE, 27 January 2022
On 27 January 2022, Gill Leng replied to my email of 31 December 2021. I have posted her reply below. Her understanding of the key issues I raise is probably greater than her reply would suggest. This selective understanding avoided addressing the issues I am most concerned about. Firstly, that NICE has entered into a… Continue reading Reply from Gill Leng, ex-CEO of NICE, 27 January 2022
Letter to Gill Leng, outgoing CEO, NICE, 31 December 2021
On 26 November 2021 I wrote to Toby Lasserson, Cochrane’s Deputy Editor-in-Chief, copying in in Gill Leng the Chief Executive Officer of NICE. I received a short response from Cochrane on 9 December. Today, 31 December, I wrote to Gill Leng, outgoing CEO of NICE copying in the incoming CEO of NICE, and other relevant… Continue reading Letter to Gill Leng, outgoing CEO, NICE, 31 December 2021